Introduction of Buchang Group

　　The Buchang group is a modern and high-tech industrial group which specializes in medical research, pharmaceutical and sales, clinic and network services. It sticks to bring products of professional quality and health, taking the benefit of the state and people as its operating purpose, and taking the long time enterprises as its development aim. In the past 10 years, it has total paid nearly USD60,000,000 as taxes. It was continuing awarded as the first paying taxes enterprise since 1997. In the year of 2000, the group was awarded as “the China Naoxintong Characteristic pharmaceutical base” by Chinese development and promotion association. In Feb. of2001, Mr. Wang Guangying, vice chairman of the People`s Congress of China awarded a medal named “the new star of China private Sin-tech enterprise” to professor Zhao Buchang, chairman of the Buchang group. In Sep., the group was elected as the main traditional Chinese medical enterprise in China. It was also awarded as the “ honesty taxes enterprise” by the state tax bureau and the national industrial and commercial association. In Feb. 2003, the group was named the “honesty enterprise” by the same occupation association of Shaanxi province once again. In Nov., the group wins a prize of technological blazing new trails again on the3rd national non-stated owned enterprise. From Dec. 13, 2003 to Dec. 16, Mr. Liuji, director of the state condition center of China, the specially appointed member of the state council, leaded delegates to investigate the Buchang group as the title of “ the 10 years development history of Shaanxi Buchang group with the new theory of Chinese non-state owned economy”.
　　 At present, the Buchang group has established its several branch groups. They are, Buchang pharmaceutical group (including Health care product), Buchang Huan Yu network group and Shaanxi international commerce and trade institute and so on. The pharmaceutical group is composed of Xianyang Buchang pharmaceutical Co., Shadong Buchang pharmaceutical Co., Beijing Zhengbang pharmaceutical Co., Dezhou Deyao pharmaceutical Co., Buchang cardio-cerebral vascular disease academy, Buchang medical research institute, Buchang medical sales Co., Beijing Buchang medical apparatus development Co., Qinghua Zhonghui biological Co., Buchang(Tianhao)pharmaceutical plant. The ten sales causes of Buchang group composes a large sales system, it has established 733 branches in the whole country. The sales of range include cardio-cerebral vascular disease medicine, instrument Chinese herbal injection, gynecological medicine, digestive medicine, chemical medicine, general medicine, OTC product and health education in the community and medical apparatus.
　　During the 10 years development, Buchang group puts focus on the development of science and technology, with 10 percent of its annual income applied into scientific research, many new high-tech products have been presented. Revealing its strong developmental momentum, such as “Buchang Wenxin granule”, “Buchang Delisheng injection”, “Longshengzhi capsule”, “Buchang Tianhao Shenshao tablet”, “Buchang Lithagogue tablet”and so on. It formulated its developmental strategy and has restored more than 50 kinds of new medicines of state, such as “Danhong Injection”, “Buchang stable plessure”, “Kelu” and so on, maintaining its leading position in this fields. All of these promote the enterprise towards to a new way developing.

　 Professor Zhao Buchang, the Chairman of board of directors of group, is a famous expert on cardio-cerebral vascular disease. The group has also established an efficient and flexible scientific managerial system. Managers in the group are all the young people whose educational level is under bachelor degree.
　　At present, the main product Buchang Naoxintong capsule has been registered and sold in Hongkong, Vitenam, Ghana, Canada, Kazakhstan, Indonesia, Russia, Singapore, Malaysia Philippine and etc, and now it have been submitted to apply for registration in India, Belarus, Ukraine, Lithuania, and so on.
　　In 2004, Buchang group entered the third five years period, standing on this new point, the Buchang group will regard to the Chinese herbal medicine modernize and internationalization as its mainstay and will depend on the continuing capital operation to realize the aim of USD1.2 billion.